Position in GILD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,608,649
-$589,314 QoQ
Shares Held
28,563
-5.2% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#663
of 2,266 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026World Investment Advisors holds $141,718,806 across 14 Drug Manufacturers - General names. GILD ranks #8 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
138,212 | $35,101,701 | |
| 2 | LLY |
ELI LILLY & Co
|
25,879 | $31,040,051 | |
| 3 | ABBV |
AbbVie Inc.
|
121,763 | $30,640,441 | |
| 4 | MRK |
Merck & Co., Inc.
|
65,711 | $8,443,863 | |
| 5 | PFE |
Pfizer Inc
|
321,367 | $7,738,517 | |
| 6 | AMGN |
Amgen Inc
|
20,040 | $7,256,884 | |
| 7 | NVS |
Novartis AG
|
44,423 | $6,961,972 | |
| 8 | GILD |
Gilead Sciences, Inc.
This page
|
28,563 | $3,608,649 |
All Filings in GILD
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,608,649 | 28,563 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $4,197,963 | 30,121 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $3,897,363 | 31,753 | Shares | Sole | 2026-03-13 | |
| 2025-09-30 | $3,126,204 | 28,164 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $3,005,796 | 27,111 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $2,953,749 | 26,361 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $2,261,864 | 24,487 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $2,179,755 | 25,999 | Shares | Sole | 2024-11-25 | |
| 2024-06-30 | $1,335,425 | 19,464 | Shares | Sole | 2024-08-15 | |
| No filing history on record for this holder in this stock. | ||||||